pharma · Ependymoma, Medulloblastoma · chronically occluded coronary artery
Ishita Pharma -
ISTA Pharma Limited
Ishita Pharma - clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Employees
- 3
- Programs
- 8
- Drugs
- 19
- Patents
- 0
Ishita Pharma - projects
7 ClinicalTrials.gov programs sponsored by Ishita Pharma -.
Ishita Pharma - has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AUTOP 2
ISTA Pharma Limited
Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities
1 trial -
Etude DAPT-CTO
ISTA Pharma Limited
chronically occluded coronary artery
1 trial -
KVD900 150 mg
ISTA Pharma Limited
Hereditary Angioedema
1 trial -
MICROPREP III
ISTA Pharma Limited
knee osteoarthritis
1 trial -
NICOTINAMIDE, cellulose microcristalline
ISTA Pharma Limited
Acute kidney injury
1 trial -
RCAPHM18_0018
ISTA Pharma Limited
Hirschsprung's disease
1 trial -
RCAPHM19_0374
ISTA Pharma Limited
Traumatism
1 trial
Frequently asked questions
How many clinical projects does Ishita Pharma - have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.